| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 05/17/2012 | US20120121604 Combination of anti-ctla4 antibody with diverse therapeutic regimens for the synergistic treatment of proliferative diseases |
| 05/17/2012 | US20120121602 Novel proteins |
| 05/17/2012 | US20120121601 Mammalian receptor proteins; related reagents and methods |
| 05/17/2012 | US20120121600 Pharmaceutical antibody compositions with resistance to soluble cea |
| 05/17/2012 | US20120121598 Compositions containing antibodies for treating cd5+hla-dr+b or t cell related diseases |
| 05/17/2012 | US20120121596 Bispecific anti-her antibodies |
| 05/17/2012 | US20120121595 FRAGMENT OF SECRETED HEAT SHOCK PROTEIN-90ALPHA (Hsp90ALPHA) AS VACCINES OR EPITOPE FOR MONOCLONAL ANTIBODY DRUGS OR TARGET FOR SMALL MOLECULE DRUGS AGAINST A RANGE OF SOLID HUMAN TUMORS |
| 05/17/2012 | US20120121592 Targeting Antigens to Human Dendritic Cells Via DC-Asialoglycoprotein Receptor to Produce IL-10 Regulatory T-Cells |
| 05/17/2012 | US20120121589 Modified egfr ectodomain |
| 05/17/2012 | US20120121587 Anti-axl antibody |
| 05/17/2012 | US20120121586 Modulators for her2 signaling in her2 expressing patients with gastric cancer |
| 05/17/2012 | US20120121583 Antibodies against human tweak and uses thereof |
| 05/17/2012 | US20120121578 Methods of using immunoglobulin aggregates |
| 05/17/2012 | US20120121576 Actriia binding agents and uses thereof |
| 05/17/2012 | US20120121575 Prohibitin as target for cancer therapy |
| 05/17/2012 | US20120121574 Antimicrobial, antiviral, anticancer and immunomodulatory peptides and uses therefore |
| 05/17/2012 | US20120121572 New medicines for topic use based on sulfated hyaluronic acid as activating or inhibiting agent of the cytokine activity |
| 05/17/2012 | US20120121570 Test for Predicting Neutralization of Asparaginase Activity |
| 05/17/2012 | US20120121559 Treatment and prevention of pathological conditions using iduna related techniques and compositions |
| 05/17/2012 | US20120121554 Hmg-coa secondary metabolites and uses thereof |
| 05/17/2012 | US20120121552 Methods for purifying hematopoietic stem cells |
| 05/17/2012 | US20120121544 Method for Efficiently Proliferating and Differentiating Natural Killer Cells from Umbilical Cord Blood |
| 05/17/2012 | US20120121541 3,5-disubstituted and 3,5,7-trisubstituted-3h-oxazolo and 3h-thiazolo[4,5-d]pyrimidin-2-one compounds and prodrugs thereof |
| 05/17/2012 | US20120121536 Compositions and methods for glucose transport inhibition |
| 05/17/2012 | US20120121535 Agent for preventing recurrence of leukemia |
| 05/17/2012 | US20120121527 NOVEL BIAROMATIC COMPOUNDS THAT MODULATE PPARy TYPE RECEPTORS AND COSMETIC/PHARMACEUTICAL COMPOSITIONS COMPRISED THEREOF |
| 05/17/2012 | US20120121517 Biodegradable and thermosensitive poly(organophosphazene)-superparamagnetic nanoparticle complex, preparation method and use thereof |
| 05/17/2012 | US20120121516 Emulsion Activatable by Ultrasounds and Method for Producing Same |
| 05/17/2012 | US20120121512 Monoclonal antibodies and their use |
| 05/17/2012 | US20120121510 Localized therapy following breast cancer surgery |
| 05/17/2012 | US20120121506 Targeting of Bone Marrow Neovasculature |
| 05/17/2012 | US20120121505 Therapeutic compositions and methods |
| 05/17/2012 | US20120121504 B cell surface reactive antibodies |
| 05/17/2012 | US20120121502 Pyrimidine hydroxy amide compounds as protein deacetylase inhibitors and methods of use thereof |
| 05/17/2012 | US20120121501 Hmgn2 peptides and related molecules that selectively home to tumor blood vessels and tumor cells |
| 05/16/2012 | EP2453017A1 Oligonucleotides for use in prophylaxis and/or treatment of TGF-beta1 and TGF-beta2, TGF-beta2 and TGF-beta3, TGF-beta1 and TGF-beta3, or TGF-beta1, TGF-beta2, and TGF-beta3 mRNA overexpressing diseases |
| 05/16/2012 | EP2453009A1 Methods of organ regeneration |
| 05/16/2012 | EP2452950A1 Antibody having anti-cancer activity |
| 05/16/2012 | EP2452948A1 New tumor marker |
| 05/16/2012 | EP2452940A1 Azabicyclo compound and salt thereof |
| 05/16/2012 | EP2452681A1 Salts of 13a-(s)desoxytylophorinine, preparation methods and pharmaceutical compositions and uses thereof |
| 05/16/2012 | EP2451952A2 Sparc antisense compositions and uses thereof |
| 05/16/2012 | EP2451945A1 Oncolytic viruses and methods for treating neoplastic disorders |
| 05/16/2012 | EP2451942A1 Preserved compositions of activated nk cells and methods of using the same |
| 05/16/2012 | EP2451817A1 Indazolyl-substituted dihydroisoxa-zolopyridines and methods of use thereof |
| 05/16/2012 | EP2451815A1 INDUCTION OF alpha-HELIX CONFORMATIONS IN PROTEINS AND PEPTIDES |
| 05/16/2012 | EP2451813A1 Heterocyclic compounds as jak receptor and protein tyrosine kinase inhibitors |
| 05/16/2012 | EP2451807A1 Cyclic triazo sodium channel blockers |
| 05/16/2012 | EP2451795A1 Compositions and methods for enhancing virus efficacy |
| 05/16/2012 | EP2451790A1 Histone deacetylase inhibitors |
| 05/16/2012 | EP2451788A1 Stable crystalline polymorphs of the dipotassium salt of (s) -2- {4- [2- (2, 4-diamin0-quinaz0lin-6-yl) -ethyl]-benzoylamino} -4-methylen -penta nedioic acid |
| 05/16/2012 | EP2451486A1 Pegylated l-asparaginase |
| 05/16/2012 | EP2451481A1 Metallic nanoparticles, preparation and uses thereof |
| 05/16/2012 | EP2451459A1 Method of reducing multi-drug resistance using inositol tripyrophosphate |
| 05/16/2012 | EP2451456A1 Combined preparation for use as a medicament |
| 05/16/2012 | EP2451451A1 Hdac 6 inhibitor-based methods for treating cancer |
| 05/16/2012 | EP2451273A1 Compositions and methods for inhibition of cancers |
| 05/16/2012 | EP2268628B1 2-aryl and 2 -heteroaryl 4h-1-benzopyran-4-one-6-amidino derivatives for the treatment of arthritis, cancer and related pain |
| 05/16/2012 | EP2254573B1 Compositions comprising phytoestrogens selective for estrogen beta receptor and dietary fibres |
| 05/16/2012 | EP1904460B1 Multidentate aza ligands able to complex metal ions and the use thereof in diagnostics and therapy |
| 05/16/2012 | EP1861425B1 Anti-mesothelin antibodies |
| 05/16/2012 | EP1860103B1 Anticancer compound, intermediate therefor, and processes for producing these |
| 05/16/2012 | EP1480993B2 Desaturase genes, enzymes encoded thereby, and uses thereof |
| 05/16/2012 | CN1575338B Bv8 nucleic acids and polypeptides with mitogenic activity |
| 05/16/2012 | CN102460175A STRUCTURE OF THE C-TERMINAL REGION OF THE INSULIN RECEPTOR a-CHAIN AND OF THE INSULIN-LIKE GROWTH FACTOR RECEPTOR a-CHAIN |
| 05/16/2012 | CN102460173A 组蛋白修饰用于癌症的临床诊断和预后 Histone modifications for clinical diagnosis and prognosis of cancer |
| 05/16/2012 | CN102459651A Method of determining response to treatment with immunomodulatory composition |
| 05/16/2012 | CN102459599A Nucleic acid modulators of glycoprotein vi |
| 05/16/2012 | CN102459589A Cdc45l peptides and vaccines including the same |
| 05/16/2012 | CN102459346A Method for making heteromultimeric molecules |
| 05/16/2012 | CN102459344A Anti-axl antibody |
| 05/16/2012 | CN102459342A Anti-il-3ra antibody for use in treatment of blood tumor |
| 05/16/2012 | CN102459340A 粒性白血细胞-巨噬细胞菌落-刺激因子(gm-csf)中和抗体 Granulocyte white blood cells - macrophage colony - stimulating factor (gm-csf) neutralizing antibody |
| 05/16/2012 | CN102459324A Casb7439构建体 Casb7439 construct |
| 05/16/2012 | CN102459314A Ttk peptides and vaccines including the same |
| 05/16/2012 | CN102459300A 用于治疗用途的新的7-脱氮嘌呤核苷 The new 7-deazapurine nucleosides for therapeutic use |
| 05/16/2012 | CN102459283A C-met 蛋白激酶的氨基吡唑三唑并噻二唑抑制剂 C-met protein kinase aminopyrazole triazolo thiadiazole inhibitor |
| 05/16/2012 | CN102459282A 作为pi3-激酶抑制剂用于治疗癌症的硫杂-三氮杂-环戊二烯并薁 Sulfur as pi3- kinase inhibitors for the treatment of cancer hetero - triaza - cyclopenta azulene |
| 05/16/2012 | CN102459272A 对P110δ具有选择性的为PI3K抑制剂的二环嘧啶化合物和使用方法 Selective for P110δ bicyclic pyrimidine compounds and methods of use for the PI3K inhibitor |
| 05/16/2012 | CN102459269A 嘌呤衍生物以及使用所述嘌呤衍生物的抗肿瘤剂 Purine derivatives and purine derivative using the anti-tumor agent |
| 05/16/2012 | CN102459267A Dihydropyrrolonaphtyridinone compounds as inhibitors of jak |
| 05/16/2012 | CN102459266A 3, 3'-螺二氢吲哚酮衍生物和它们用于癌症的用途 Uses 3, 3'-spiro-indolinone derivatives and their use for cancer |
| 05/16/2012 | CN102459265A 激酶活性的嘧啶抑制剂 Pyrimidine inhibitors of kinase activity |
| 05/16/2012 | CN102459264A 激酶活性的嘧啶抑制剂 Pyrimidine inhibitors of kinase activity |
| 05/16/2012 | CN102459262A 抑制raf蛋白激酶的吡咯并[2，3.b]吡啶 Inhibition of raf protein kinase pyrrolo [2,3.b] pyridine |
| 05/16/2012 | CN102459261A 用于治疗变性和炎性疾病的新化合物 The new compounds for treating degenerative and inflammatory diseases for |
| 05/16/2012 | CN102459260A 1H-吡唑并[4，3-c]异喹啉衍生物、其制备方法及其治疗用途 1H- pyrazolo [4,3-c] isoquinoline derivatives, their preparation and their therapeutic use |
| 05/16/2012 | CN102459253A Oxazole substituted indazoles as pi3-kinase inhibitors |
| 05/16/2012 | CN102459252A 用于治疗糖原合酶激酶3相关疾病诸如阿尔茨海默病的咪唑取代的嘧啶 For the treatment of glycogen synthase kinase 3-related diseases such as Alzheimer's disease pyrimidine substituted imidazole |
| 05/16/2012 | CN102459249A 作为PI3K/mTOR抑制剂的苯并氧氮杂环庚三烯以及它们使用与制造方法 As the PI3K / mTOR inhibitor benzoxazepine cycloheptatriene and their use and manufacturing method |
| 05/16/2012 | CN102459248A 作为PI3K/mTOR抑制剂的苯并氧杂环庚三烯以及它们使用与制造方法 As the PI3K / mTOR inhibitor benzoxepin-triene and their method of use and manufacture |
| 05/16/2012 | CN102459238A 2，3-二氢-1h-茚化合物及其治疗癌症的用途 2,3-dihydro--1h- indene compounds and their use in the treatment of cancer |
| 05/16/2012 | CN102459234A 作为p70s6激酶抑制剂的取代的苯并三嗪类和喹喔啉类 As the substituted benzo triazines and quinoxaline p70s6 kinase inhibitor |
| 05/16/2012 | CN102459233A 二取代的酞嗪hedgehog途径拮抗剂 Disubstituted phthalazine hedgehog pathway antagonists |
| 05/16/2012 | CN102459224A 5-alkynyl-pyridines |
| 05/16/2012 | CN102459221A 噻吩衍生物 Thiophene derivative |
| 05/16/2012 | CN102459204A 溶血磷脂酸受体的多环拮抗剂 Lysophosphatidic acid receptor antagonists polycyclic |
| 05/16/2012 | CN102459201A 杀真菌的1，2，4-三唑衍生物 Fungicidal 1,2,4-triazole derivatives |
| 05/16/2012 | CN102459193A 抗癌化合物和含有该化合物的药物组合物 Anti-cancer compounds and pharmaceutical compositions containing the compound |
| 05/16/2012 | CN102459188A 新型6-芳氨基吡啶酮磺酰胺和6-芳氨基吡嗪酮磺酰胺mek抑制剂 Novel 6-aryl-amino-pyridone and 6-aryl sulfonamide amino pyrazinone sulfonamide inhibitors mek |